Categories AlphaGraphs, Earnings, Health Care

ABBV Infographic: AbbVie’s Q1 2023 earnings and revenue decline

Pharmaceutical company AbbVie, Inc. (NYSE: ABBV) reported a decrease in first-quarter 2023 adjusted earnings and revenues. The company also provided guidance for fiscal 2023.

AbbVie Q1 2023 earnings infographic

Total revenues decreased 9.7% year-over-year to $12.23 billion, reflecting weakness in the main operating segments.

At $2.46 per share, adjusted net income was lower than the $3.16 per share reported in the prior-year period. First-quarter unadjusted profit dropped to $239 million or $0.13 per share from $4.49 billion or $2.51 per share in the first quarter of 2022.

“This year is off to an excellent start, with first-quarter revenues and EPS ahead of our expectations, driven by strong commercial execution across all areas of our diversified portfolio,” said Richard A. Gonzalez, CEO of AbbVie.

Prior Performance

  • AbbVie-Q4-2022-Earnings-Infographic
  • AbbVie Q3 2022 earnings infographic
  • Abbvie Q2 2022 earnings infographics

Most Popular

Earnings Preview: UnitedHealth looks poised to end FY24 on a positive note

UnitedHealth Group (NYSE: UNH), a leading provider of health insurance and healthcare services, is expected to report fourth-quarter earnings next week. The company, a market leader in the nation's colossal

Mattel (MAT): A look at the toymaker’s evolving strategy and its opportunities

Shares of Mattel, Inc. (NASDAQ: MAT) stayed green on Wednesday. The stock has dropped 4% over the past month. Over the past few years, the toymaker has been focused on

AngioDynamics (ANGO) reports net loss for Q2 2025; sales drop 8%

AngioDynamics Inc. (NASDAQ: ANGO) reported a net loss for the second quarter of 2025 as the medical device company’s revenues decreased 8%. Net loss, excluding special items, was $0.04 per

Add Comment
Loading...
Cancel
Viewing Highlight
Loading...
Highlight
Close